Description
EMPAFLO M 12.5/500mg, supplied in a pack of 30 tablets, is a dual-action medication for the effective management of type 2 diabetes in adults. Each tablet combines Empagliflozin 12.5mg, an SGLT2 inhibitor that helps kidneys remove excess glucose via urine, and Metformin Hydrochloride 500mg, a biguanide that reduces glucose production by the liver and improves insulin sensitivity. This synergistic combination provides robust blood sugar control. Beyond glycemic benefits, EMPAFLO M 12.5/500mg also plays a crucial role in reducing the risk of cardiovascular death, hospitalization for heart failure, and progression of chronic kidney disease in eligible patients. Used alongside diet and exercise, it offers comprehensive support for overall diabetes health
